California State Teachers Retirement System (CalSTRS)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.9M | Sell |
123,943
-16,773
| -12% | -$495K | ﹤0.01% | 1231 |
|
|
2026
Q1 | $3.48M | Buy |
140,716
+30,717
| +28% | +$732K | ﹤0.01% | 1223 |
|
|
2025
Q4 | $2.57M | Sell |
109,999
-100
| -0.1% | -$2.23K | ﹤0.01% | 1281 |
|
|
2025
Q3 | $2.17M | Buy |
110,099
+10,842
| +11% | +$223K | ﹤0.01% | 1359 |
|
|
2025
Q2 | $2.15M | Buy |
99,257
+992
| +1% | +$23.4K | ﹤0.01% | 1327 |
|
|
2025
Q1 | $2.38M | Sell |
98,265
-1,965
| -2% | -$44.3K | ﹤0.01% | 1239 |
|
|
2024
Q4 | $2.09M | Sell |
100,230
-727
| -0.7% | -$15.6K | ﹤0.01% | 1383 |
|
|
2024
Q3 | $2.01M | Sell |
100,957
-3,750
| -4% | -$69.5K | ﹤0.01% | 1411 |
|
|
2024
Q2 | $1.62M | Sell |
104,707
-1,650
| -2% | -$25.7K | ﹤0.01% | 1499 |
|
|
2024
Q1 | $1.7M | Buy |
106,357
+4,346
| +4% | +$65.5K | ﹤0.01% | 1515 |
|
|
2023
Q4 | $1.71M | Sell |
102,011
-9,558
| -9% | -$131K | ﹤0.01% | 1538 |
|
|
2023
Q3 | $1.3M | Sell |
111,569
-8,828
| -7% | -$118K | ﹤0.01% | 1640 |
|
|
2023
Q2 | $1.62M | Sell |
120,397
-2,554
| -2% | -$36.8K | ﹤0.01% | 1615 |
|
|
2023
Q1 | $2.04M | Sell |
122,951
-779
| -0.6% | -$12.9K | ﹤0.01% | 1464 |
|
|
2022
Q4 | $2.3M | Buy |
123,730
+1,875
| +2% | +$28.9K | ﹤0.01% | 1396 |
|
|
2022
Q3 | $1.56M | Sell |
121,855
-2,966
| -2% | -$35.2K | ﹤0.01% | 1598 |
|
|
2022
Q2 | $875K | Buy |
124,821
+94
| +0.1% | +$689 | ﹤0.01% | 2047 |
|
|
2022
Q1 | $1.03M | Sell |
124,727
-10,765
| -8% | -$76.1K | ﹤0.01% | 2015 |
|
|
2021
Q4 | $917K | Buy |
135,492
+2,866
| +2% | +$18.8K | ﹤0.01% | 2214 |
|
|
2021
Q3 | $703K | Sell |
132,626
-1,550
| -1% | -$8.48K | ﹤0.01% | 2340 |
|
|
2021
Q2 | $772K | Sell |
134,176
-14,002
| -9% | -$72.3K | ﹤0.01% | 2383 |
|
|
2021
Q1 | $683K | Buy |
148,178
+2,427
| +2% | +$9.64K | ﹤0.01% | 2372 |
|
|
2020
Q4 | $487K | Hold |
145,751
| – | – | ﹤0.01% | 2432 |
|
|
2020
Q3 | $433K | Buy |
145,751
+57
| +0% | +$223 | ﹤0.01% | 2351 |
|
|
2020
Q2 | $673K | Hold |
145,694
| – | – | ﹤0.01% | 2094 |
|
|
2020
Q1 | $561K | Sell |
145,694
-4,621
| -3% | -$19K | ﹤0.01% | 2002 |
|
|
2019
Q4 | $564K | Hold |
150,315
| – | – | ﹤0.01% | 2284 |
|
|
2019
Q3 | $798K | Buy |
150,315
+1,550
| +1% | +$8.26K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $571K | Hold |
148,765
| – | – | ﹤0.01% | 2283 |
|
|
2019
Q1 | $759K | Sell |
148,765
-20,339
| -12% | -$59.8K | ﹤0.01% | 2089 |
|
|
2018
Q4 | $325K | Buy |
169,104
+20,510
| +14% | +$58.7K | ﹤0.01% | 2536 |
|
|
2018
Q3 | $562K | Buy |
148,594
+976
| +0.7% | +$3.06K | ﹤0.01% | 2393 |
|
|
2018
Q2 | $461K | Buy |
147,618
+14,356
| +11% | +$43.6K | ﹤0.01% | 2487 |
|
|
2018
Q1 | $318K | Buy |
133,262
+20,484
| +18% | +$68.1K | ﹤0.01% | 2590 |
|
|
2017
Q4 | $441K | Sell |
112,778
-4,822
| -4% | -$15.9K | ﹤0.01% | 2465 |
|
|
2017
Q3 | $296K | Sell |
117,600
-9,100
| -7% | -$25K | ﹤0.01% | 2692 |
|
|
2017
Q2 | $350K | Buy |
+126,700
| New | +$264K | ﹤0.01% | 2674 |
|
|
2016
Q2 | – | Sell |
-162,381
| Closed | -$190K | – | 3009 |
|
|
2016
Q1 | $190K | Buy |
162,381
+22,808
| +16% | +$35.4K | ﹤0.01% | 2819 |
|
|
2015
Q4 | $342K | Buy |
139,573
+2,494
| +2% | +$7.14K | ﹤0.01% | 2645 |
|
|
2015
Q3 | $411K | Sell |
137,079
-500
| -0.4% | -$2.16K | ﹤0.01% | 2550 |
|
|
2015
Q2 | $568K | Buy |
+137,579
| New | +$548K | ﹤0.01% | 2466 |
|
Other funds holding CPRX
GCL
HI
California State Teachers Retirement System (CalSTRS)'s CPRX Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Catalyst Pharmaceutical (CPRX) stake by 12% in Q2 2026, selling an estimated $495K and leaving 123,943 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.
California State Teachers Retirement System (CalSTRS) first reported a position in CPRX in Q2 2015 and has held it in 41 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 123,943 shares of Catalyst Pharmaceutical worth $3.9M as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 16,773 Catalyst Pharmaceutical shares in Q2 2026, an estimated $495K.
- Catalyst Pharmaceutical made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1231 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Catalyst Pharmaceutical in Q2 2015 and has held it in 41 quarters since.
- 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.